Govt. to improve availability of infrastructure and trained manpower for organ transplantation
Stressed was on the need to promote organ donation from the deceased persons to meet the huge need for organ donation in the country
Stressed was on the need to promote organ donation from the deceased persons to meet the huge need for organ donation in the country
Biocon Biologics earlier announced a settlement agreement in the United States for a Bmab 1200 launch no later than February 22, 2025
The company is making its mark through strategic initiatives, promising to become a significant presence in the evolving pharmaceutical sector
First-in-human Phase-1 study will evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of SUVN-I6107 in healthy subjects
Brimonidine Tartrate Ophthalmic Solution, 0.1% is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure
The low-profile, 2” Disc Top Lite closure offers lighter weight combined with premium customization options
Also received tentative approval for 137 mg
Subscribe To Our Newsletter & Stay Updated